bpc-157 cuprizone demyelination Frontiers Ferroptosis Mediates Cuprizone-Induced Loss of

Most vials dissolve within 2-5 minutes of gentle rolling

Many clients report an improvement in energy and alertness within 24 to 72 hours of their first injection

BPC-157 (Body Protective Compound 157) is a synthetic peptide derived from a protein found in the stomach

Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies

One of the most common concerns about peptide therapy is the idea of administering injections at home

Any cloudiness, particles, or color change suggests problems